Global Markets Direct’s, ‘Brain Injury – Pipeline Review, H1 2015′, provides an overview of the Brain Injury’s therapeutic pipeline.

Brain injury occurs due to external force on the brain such as a blow to the head that causes the brain to move inside the skull or damages the skull. Common causes of closed head injury include automobile accidents, falls, work-related accidents, and sports-related accidents. Symptoms of severe closed head injury usually present themselves immediately, while symptoms of mild head injury can show up days or even weeks after an injury. The common symptoms are Loss of consciousness, Headache and Respiratory issues.

This report provides comprehensive information on the therapeutic development for Brain Injury, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Brain Injury and special features on late-stage and discontinued projects.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Complete Report is Available at http://www.rnrmarketresearch.com/brain-injury-pipeline-review-h1-2015-market-report.html  .

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

Scope:

• The report provides a snapshot of the global therapeutic landscape of Brain Injury.
• The report reviews key pipeline products under drug profile section which includes product description, MoA and R&D brief, licensing and collaboration details & other developmental activities.
• The report reviews key players involved in the therapeutics development for Brain Injury and enlists all their major and minor projects.
• The report summarizes all the dormant and discontinued pipeline projects.
• A review of the Brain Injury products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
• Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages.

Order a Purchase copy of this report at http://www.rnrmarketresearch.com/contacts/purchase?rname=269612 . (This is a premium report priced at US$2000 for a single user License.)

Reasons to Buy:

• Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies.
• Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
• Develop strategic initiatives by understanding the focus areas of leading companies.
• Identify and understand important and diverse types of therapeutics under development for Brain Injury.
• Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline.
• Devise corrective measures for pipeline projects by understanding Brain Injury pipeline depth and focus of Indication therapeutics.
• Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.

Explore more reports on Pharmaceuticals at http://www.rnrmarketresearch.com/reports/life-sciences/pharmaceuticals .